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Abstract
Anterior Cruciate Ligament (ACL) injuries are an upsetting setback for 
many athletes that require a long and costly recovery process. The 
injury rates are four times greater in women than men. Preventative 
measures that help to prevent ACL injuries are limited to stretching 
and strengthening. Therefore, this review aims to investigate if oral 
contraceptive [I] usage provides a possible new avenue for prevention 
of ACL injury [O] in young female athletes (ages 18-30) [P] compared 
to those that do not take oral contraceptives [C]. 
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Introduction
Methods
• Performed in October 2018 using 
• PubMed
• Google Scholar 
• SCOPUS
• ClinicalKey
• Search Terms: 
• “ACL” AND “oral contraceptives” 
• “menstrual cycle” AND “ACL injury” AND 
“oral contraceptives”
• “ACL injury” OR “joint laxity” AND “oral 
contraceptive”.  
‘
• Inclusion Criteria:  
• Published in peer-reviewed journal 
• Published within last 10 years
• Human participants as subjects
• Female participants
• Age range 18-30 y/o
• Exclusion Criteria:
• Systematic reviews or meta-analyses
• Male participants
• Injuries other than ACL 
• Ages other than 18-30 y/o
3/4 studies that analyzed % of ACL tear in OCP users vs non-users found less risk in OCP users; the other found no 
significant difference. 
2/2 studies that measured anterior tibial translation in OCP users vs non-users found significantly less translation in OCP-
users.
Strengths
• Statistically significantà All utilized 2 methods of data analyses and all p value < 0.05
• 8/8 used inclusion/exclusion criteria, which resulted in decreased amount of  confounding variables 
Limitations
• Large differences in sample sizes 
• Low external validity à none measured duration of OCP treatment nor described what type/strength of OCP 
• None measured how long participants had been on OCP treatment
• Lack of long-term follow up
Future Research
• Inclusion/exclusion criteria applied in order to account for type/strength of OCP and duration 
• Obtain information such as level of compliance and what day of the menstrual cycle the tears were on
• Obtain follow up and compare recovery rates in OCP users vs non-users
• More laboratory experiments on cadaver ACLs testing various forms of estrogen, progesterone, and measuring serum relaxin-2. 
Discussion Results 
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Oral Contraceptives as Possible ACL Injury Prevention Method
The study reveals a significant difference in OCP-users vs non-users in terms of joint laxity and % of overall ACL tears. 
Although there are limitations to some of this research, it provides a great blueprint for future studies and provokes some 
great ideas for clinical practice.
The determination of utilizing OCP in the future for ACL prevention should be made on a case by case basis. Potential 
contraindications such as personal or family history of breast cancer or clotting disorders must be taken into consideration.
Many questions and technical issues regarding how to best utilize OCPs must first be determined prior to bringing this into 
clinical practice- specifically, the duration, form, and strength of the OCP usage. This should be the aim of future research.
Until more research is performed and these questions are answered, it remains unclear if OCPs are a safe and effective 
preventative measure for ACL injury.. There is not yet enough evidence to safely utilize this in practice yet.  
Overall, the meta-analysis reveals positive outcomes in utilizing OCPs as a preventative measure in ACL injury, but the 
evidence is insufficient to begin use in clinical practice.  
Conclusion
Key: OCP= Oral Contraception, ACL= Anterior Cruciate Ligament, KT-1000= Knee Laxity 
Testing Device,  MMP1= collagenase-1, MMP3= stromelysin-1, MMP13= collagenase-3
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Anterior Cruciate Ligament (ACL) injury
Statistics
• ACL injury rates 4x > in F:M
• Roughly 200,000 tears per year in US as of 2017
• Reconstructive treatments= ~ $7.6 billion per year
• Rehabilitative treatments= ~ $17.7 billion per year
Physiology 
• Estrogen has effect on collagen, altering its tensile properties of ligaments in ACL 
fibroblast 
• Neuromuscular performance varies during the menstrual cycle
• Elevated serum relaxin-2 levels correlate with increased ACL injuries.  
Current Prevention
• Stretching, strengthening, and mobility exercises aimed to release tension and 
tightness on the joint and strengthen muscles around the knee joint
Study Population
Demographics
Control Exclusion Criteria Tx 
Compared
Outcome Measure
1 83 Females Non OCP users None OCP users % of ACL injuries
2 347,118 Females Healthy age-matched 
female ACL  (3:1)
History of hormonal disruptive 
condition, PCOS, hysterectomy, 
Turner syndrome, 
follicular/ovarian cyst, atrophy of 
ovary/fallopian tube, 
benign/malignant neoplasm of 
ovary, oophorectomy, pregnant 
state/ectopic in last 12 mo.
Emergency contraception, 
implantable devices, hormonal 
IUDs, injectable/patch 
contraceptives
OCP users % undergoing ACL 
repair
3 53 Females Non OCP users For control: no previous history 
of knee injury or anomalies and 
normal 28-30 day menstrual 
cycle
OCP users KT-1000 
measurements of 
anterior tibia 
translation
4 7 Males, 7 Females
F Ages:  19, 40, 20, 13, 46, 43, 
20
M ages: 36, 23, 26, 51, 20, 19, 
26
Race: Hispanic (1), White (10), 
American Indian (1), Asian (2)
None Prior ACL injury Treated 
with 
concentrati
ons of 
relaxin-2 or 
TGFβ1 or 
17β-
estradiol
MMP1, MMP3, 
MMP13, type I 
collagen, type III 
collagen,  mRNA
5 172 Females
(mean age 34 +/- 8.7 
years)
Non OCP users None OCP users % of ACL injuries
6 172 Females None None OCP users KT-1000 
measurements of 
anterior tibia 
translation
7 106  Females
13 amenorrhea, 77 regular 
menstruation, 16 prior OC 
usage
Non OCP users Serum relaxin-2 < 6.0 pg/mL OCP users Hormone levels from 
blood samples 
(serum-relaxin 2)  
8 13,355 Females
Median age= 24 y/o 
Healthy age-matched 
female ACL (2:1) 
For the controls: prior ACL 
injury
OCP users % ACL injuries
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